Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience

Dermatol Pract Concept. 2024 Jul 1;14(3):e2024179. doi: 10.5826/dpc.1403a179.
No abstract available

Publication types

  • Letter